Trial intelligence / Profile preview

VRVg-2 Rabies Vaccine in Pediatric and Adult Populations

NCT04127786Phase 3Completed

Sponsor
Sanofi
Start
Oct 2019
Primary completion
Mar 2020
Modality
Whole Inactivated Vaccines
Countries
1
01

Overview

A Phase 3 trial of Rabies vaccine in rabies, sponsored by Sanofi. Started Oct 2019; status: completed.

02

Drugs

Rabies vaccine
03

Conditions

rabies

Beyond the preview

Go deeper on NCT04127786.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04127786.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call